Tag: Cancer Risk Reduction

Emerging research suggests that GLP-1 and GIP antagonists may offer benefits beyond weight management and diabetes control. Some studies indicate a potential link between these medications and a reduced risk of certain cancers, particularly those associated with obesity, such as colorectal, endometrial, and breast cancers. The mechanisms by which GLP-1 and GIP antagonists may reduce… Read more